RxDoctor Payments Data

Zaki Ibrahim, MD

Orthopaedic Surgery of the Spine · Clive, IANPI 1689612889

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (32.4%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Surgalign Spine Technologies, Inc. at 55.9% of the total. Reporting peaked in 2019 at $8,860 and has fallen 91.8% since, to $722 in 2025.

$18,641in general payments, 2019–2025

Across 70 payments — averaging $266.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgalign Spine Technologies, Inc.$10K
  • Xtant Medical Inc$4K
  • Globus Medical$2K
  • Biotronik NRO, Inc.$1K
  • Medtronic$607
  • Ziehm-orthoscan, Inc.$302
  • plus $793 from 10 others

What the payments were for

  • Royalty or licence$4,55424%
  • Consulting fees$6,04532%
  • Travel & lodging$4,48824%
  • Food & beverage$3,55319%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic surgery of the spine providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$95,975
Medicare patients
127
Services billed
466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium82$620
Oxycodone Hcl61$543
Methocarbamol57$383
Tramadol Hcl35$148
Methylprednisolone14$117
Meloxicam39$92

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Clive

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →